These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 644255)

  • 1. Activation of complement by stroma from normal and paroxysmal nocturnal haemoglobinuria red cells.
    De Sandre G; Corrocher R; Falezza GC; Aprili G; Caffi S
    Scand J Haematol; 1978 Mar; 20(3):265-70. PubMed ID: 644255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.
    Parker CJ; Wiedmer T; Sims PJ; Rosse WF
    J Clin Invest; 1985 Jun; 75(6):2074-84. PubMed ID: 4008653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement inhibitor S protein is associated with membranes of red blood cells from patients with paroxysmal nocturnal haemoglobinuria.
    Salama A; Preissner KT; Göttsche B; Müller-Berghaus G; Mueller-Eckhardt C
    Br J Haematol; 1988 Jan; 68(1):41-5. PubMed ID: 3345295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.
    Logue GL; Rosse WF; Adams JP
    J Clin Invest; 1973 May; 52(5):1129-37. PubMed ID: 4700488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of heparin on complement activation and lysis of paroxysmal nocturnal hemoglobinuria (PNH) red cells.
    Logue GL
    Blood; 1977 Aug; 50(2):239-47. PubMed ID: 17439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of human erythrocyte stromata on complement activation.
    Corrocher R; Tedesco F; Rabusin P; De Sandre G
    Br J Haematol; 1975 Feb; 29(2):235-41. PubMed ID: 33
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-lymphocytes escape membrane defect in paroxysmal nocturnal haemoglobinuria.
    Cooper MR; Currie MS; Rustagi PK; Logue GL
    Br J Haematol; 1983 Oct; 55(2):263-71. PubMed ID: 6604541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis.
    Rosse WF; Hoffman S; Campbell M; Borowitz M; Moore JO; Parker CJ
    Br J Haematol; 1991 Sep; 79(1):99-107. PubMed ID: 1716964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP
    J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation of the acetylcholinesterase-deficient red cells in paroxysmal nocturnal hemoglobinuria.
    Chow FL; Hall SE; Rosse WF; Telen MJ
    Blood; 1986 Apr; 67(4):893-7. PubMed ID: 3955235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eculizumab treatment: stochastic occurrence of C3 binding to individual PNH erythrocytes.
    Sica M; Rondelli T; Ricci P; De Angioletti M; Risitano AM; Notaro R
    J Hematol Oncol; 2017 Jun; 10(1):126. PubMed ID: 28629435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of complement-mediated haemolysis in paroxysmal nocturnal haemoglobinuria by heparin or low-molecular weight heparin.
    Ninomiya H; Kawashima Y; Nagasawa T
    Br J Haematol; 2000 Jun; 109(4):875-81. PubMed ID: 10929045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes.
    Medof ME; Gottlieb A; Kinoshita T; Hall S; Silber R; Nussenzweig V; Rosse WF
    J Clin Invest; 1987 Jul; 80(1):165-74. PubMed ID: 2439544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of complement derived from the erythrocyte membrane in paroxysmal nocturnal hemoglobinuria.
    Chua C; Hoffmann EM; Adams JP; Rosse WF
    Blood; 1980 May; 55(5):772-6. PubMed ID: 7362868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxysmal nocturnal haemoglobinuria with coexisting deficiency of the ninth component of complement: lack of massive haemolytic attack.
    Yonemura Y; Kawakita M; Koito A; Kawaguchi T; Nakakuma H; Kagimoto T; Schichishima T; Terasawa T; Akagaki Y; Inai S
    Br J Haematol; 1990 Jan; 74(1):108-13. PubMed ID: 2310692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.
    Nicholson-Weller A; March JP; Rosenfeld SI; Austen KF
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5066-70. PubMed ID: 6576376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relations between surface charge and in vitro lysis of red blood cells in paroxysmal nocturnal haemoglobinuria.
    Hause LL; Koethe SM; Rothwell DJ; Straumfjord JV
    Scand J Haematol; 1978 Feb; 20(2):141-6. PubMed ID: 635466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor.
    Medof ME; Kinoshita T; Silber R; Nussenzweig V
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2980-4. PubMed ID: 2581259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Paroxysmal nocturnal hemoglobinuria. Increase in proteins of the alternative complement pathway].
    de Gramont A; Kazatchkine M; Maillet F; Blanche M; Debray J
    Presse Med; 1983 Mar; 12(12):747-50. PubMed ID: 6220312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An examination of complement proteins on membranes of paroxysmal nocturnal haemoglobinuria (PNH) and PNH-like red cells.
    Burapakulsolsri N; Yuthavong Y; Wilairat P
    Br J Haematol; 1979 Mar; 41(3):393-8. PubMed ID: 427043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.